Petinimid 250 mg (Ethosuximide)

Petinimid 250 mg (Ethosuximide) is an antiepileptic medication used primarily for the treatment of absence seizures (“petit mal” seizures). It reduces abnormal neuronal activity in the brain and helps control the frequency of epileptic episodes.

Active ingredient:

• Ethosuximide 250 mg

Dosage form:

• Capsules
• Pack: 100 capsules

Indications:

• Absence epilepsy
• Petit mal seizures in children and adults
• May be used as monotherapy or in combination with other antiepileptic drugs

Mechanism of action:

Ethosuximide decreases neuronal hyperexcitability in the thalamus, suppressing abnormal electrical activity. This makes it one of the most effective medications for controlling absence seizures.

Benefits of Petinimid:

• Proven efficacy in absence seizures
• Generally well tolerated
• Suitable for long-term therapy
• Produced by trusted European manufacturer Gerot Lannach

Administration:

The dosage is determined by a healthcare professional. Usually taken orally with water on a daily basis.

Contraindications:

• Hypersensitivity to ethosuximide
• Severe liver or kidney disorders
• Pregnancy or breastfeeding (only under medical supervision)

Possible side effects:

• Drowsiness
• Dizziness
• Gastrointestinal issues
• Mood changes
• Rarely: hematologic disorders (require monitoring)

Ask a question or inquire about delivery to your country

Telegram

WhatsApp